Importer of Controlled Substances Registration, 27632-27633 [2018-12670]
Download as PDF
<![CDATA[
27632
Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices
Dated: June 1, 2018.
Robert W. Patterson,
Acting Administrator.
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 13, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
[FR Doc. 2018–12686 Filed 6–12–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
ACTION:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
SUPPLEMENTARY INFORMATION:
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Pharmaceutical Materials Inc.
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on January
1, 2018, Johnson Matthey
Pharmaceutical Materials Inc., 25 Patton
Road, Devens, MA 01434 applied to be
registered as a bulk manufacturer for the
basic classes of controlled substances:
Controlled substance
Drug code
Amphetamine ...................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk for distribution to its customers as
well as to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Dated: June 6, 2018.
John J. Martin,
Assistant Administrator.
Notice of registration.
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as importers of
SUMMARY:
[FR Doc. 2018–12685 Filed 6–12–18; 8:45 am]
BILLING CODE 4410–09–P
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
FR docket
amozie on DSK3GDR082PROD with NOTICES1
18:01 Jun 12, 2018
Jkt 244001
protocols in effect on May 1, 1971. The
DEA investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
PerkinElmer, Inc ...................................................................................................................................................
Stepan Company ..................................................................................................................................................
Noramco, Inc ........................................................................................................................................................
Sanyal Biotechnology ...........................................................................................................................................
S&B Pharma, Inc ..................................................................................................................................................
Siegfried USA, LLC ..............................................................................................................................................
Lannett Company, Inc ..........................................................................................................................................
VerDate Sep<11>2014
1100
1724
7379
9193
9220
9737
9739
9740
various classes of schedule I or II
controlled substances.
Company
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrants to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
Schedule
83
83
83
83
83
83
83
FR
FR
FR
FR
FR
FR
FR
9337
9337
12408
12407
13523
13521
13520
Published
March
March
March
March
March
March
March
5, 2018.
5, 2018.
21, 2018.
21, 2018.
29, 2018.
29, 2018.
29, 2018.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
E:\FR\FM\13JNN1.SGM
13JNN1
27633
Federal Register / Vol. 83, No. 114 / Wednesday, June 13, 2018 / Notices
Dated: May 30, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–12670 Filed 6–12–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cambrex Charles City
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 13, 2018. Such persons
may also file a written request for a
DATES:
hearing on the application on or before
July 13, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
10, 2018, Cambrex Charles City, 1205
11th Street, Charles City, IA 50616
applied to be registered as an importer
of the following basic classes of
controlled substances:
Controlled substance
Drug code
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Phenylacetone .................................................................................................................................................................
Coca Leaves ....................................................................................................................................................................
Opium, raw ......................................................................................................................................................................
Poppy Straw Concentrate ...............................................................................................................................................
The company plans to import the
listed controlled substances for internal
use, and to manufacture bulk
intermediates for sale to its customers.
Dated: June 6, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–12683 Filed 6–12–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Bellwyck Clinical Services
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
amozie on DSK3GDR082PROD with NOTICES1
DATES:
issuance of the proposed registration on
or before July 13, 2018. Such persons
may also file a written request for a
hearing on the application on or before
July 13, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
Drug code
Amphetamine ........................................................................................................................................................
Methylphenidate ....................................................................................................................................................
Oxycodone ............................................................................................................................................................
18:01 Jun 12, 2018
Jkt 244001
PO 00000
Frm 00096
Fmt 4703
8333
8501
9040
9600
9670
Sfmt 4703
II
II
II
II
II
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
4, 2018, Bellwyck Clinical Services,
8946 Global Way, West Chester, OH
45069 applied to be registered as an
importer of the following basic classes
of controlled substances:
Controlled substance
VerDate Sep<11>2014
Schedule
E:\FR\FM\13JNN1.SGM
13JNN1
1100
1724
9143
Schedule
II
II
II
]]>Agencies
[Federal Register Volume 83, Number 114 (Wednesday, June 13, 2018)]
[Notices]
[Pages 27632-27633]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12670]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by-the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
PerkinElmer, Inc............. 83 FR 9337 March 5, 2018.
Stepan Company............... 83 FR 9337 March 5, 2018.
Noramco, Inc................. 83 FR 12408 March 21, 2018.
Sanyal Biotechnology......... 83 FR 12407 March 21, 2018.
S&B Pharma, Inc.............. 83 FR 13523 March 29, 2018.
Siegfried USA, LLC........... 83 FR 13521 March 29, 2018.
Lannett Company, Inc......... 83 FR 13520 March 29, 2018.
------------------------------------------------------------------------
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of the listed registrants to import the applicable basic
classes of schedule I or II controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each company's maintenance of effective
controls against diversion by inspecting and testing each company's
physical security systems, verifying each company's compliance with
state and local laws, and reviewing each company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed companies.
[[Page 27633]]
Dated: May 30, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-12670 Filed 6-12-18; 8:45 am]
BILLING CODE 4410-09-P
